In the panorama of international nutraceutical research, the study OleoMetS (Olive Oil Polyphenols and Metabolic Syndrome) – the result of a prestigious international collaboration that brought together research centers of excellence in Cyprus, Greece, and the United States – represents a fundamental turning point. It is no longer just a matter of generically praising the benefits of the Mediterranean diet, but of mapping with surgical precision how specific compounds of extra virgin olive oil (EVOO), i polyphenols, can act as real metabolic modulators in subjects already at risk.
The metabolic syndrome identikit
Metabolic syndrome is a “perfect storm” of risk factors: abdominal obesity, hypertension, high triglyceride levels, low HDL cholesterol levels, and impaired fasting glucose. It affects approximately 25% of the world's adult population., placing itself as theantechamber of chronic disabling diseases such as type 2 diabetes and myocardial infarctionThe aim of the OleoMetS study was to verify whether concentrated polyphenol supplementation could reverse these parameters without initially resorting to aggressive pharmacological interventions.
The sample and the methodology
The study involved ain a clinical sample of 100 subjects (men and women aged between 40 and 70), all diagnosed with metabolic syndrome according to international criteria. The duration of observation was 8 weeks, sufficient time to observe significant changes in systemic biological responses.
Participants were divided into two main groups using a double-blind protocol:
Intervention group: received a standardized daily supplement of olive-derived polyphenols.
Control group: he received an inert substance, maintaining the same eating habits.
The quantities administered
The key to the study lies in dose. Many commercial oils lose a large portion of their polyphenols during storage or cooking. The OleoMetS study used a titrated extract that provided 50 mg of total polyphenols per day; this included approximately 10–15 mg of hydroxytyrosol (the most potent phenol in terms of antioxidant capacity) and a significant amount of oleuropein, which improves insulin sensitivity.
To give an idea of the effectiveness, to obtain 50 mg of polyphenols from common olive oil (which often contains only 200 mg/kg), an individual would have to consume almost 250 ml per day, an unsustainable caloric load. Supplementation has allowed the biochemical benefits to be isolated without the excess fat.
The results: what has changed
At the end of the 8 weeks, the results collected by the researchers showed a clear difference between the two groups.
- Cardiovascular protection: a reduction in systolic blood pressure (the “maximum”) was recorded and, above all, a drastic decrease in oxidized LDL levels. The latter is the real culprit of atherosclerosis: cholesterol only becomes dangerous when oxidized, and the polyphenols in OleoMetS acted as a biological “shield”;
- Glycemic control: Those in the intervention group showed an improvement in their HOMA score, which measures insulin resistance. Essentially, their bodies regained better control of blood sugar levels;
- Reduction of inflammation: Chronic inflammation markers (such as C-Reactive Protein) dropped significantly, reducing the state of “silent inflammation” typical of visceral obesity.
A new therapeutic frontier
The OleoMetS data suggest that Olive polyphenols are not only antioxidants, but molecules capable of influencing gene expression linked to the metabolism of fats and sugars.This study paves the way for the use of high-quality supplements as standard clinical support for those suffering from metabolic syndrome, offering a natural, safe, and scientifically validated solution.
